Browsing: reports

Calif., Aug. 4, 2026 /PRNewswire/ — IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed to the discovery, development and commercialization of targeted therapeutics, today reported financial results for the second quarter ended June 30, 2026, and provided a business update

PEDEVCO (PED) reports mutual departure of Chief Accounting Officer Pinkston Filing Impact (Moderate) Filing Sentiment (Neutral) Form Type Rhea-AI Filing Summary PEDEVCO Corp. reported a leadership change in its finance organization. On and effective June 23, 2026, the company and Paul Pinkston mutua…